Evidence map›Paper›PMID 41893410›Full record

ArticleTropical medicine and infectious disease2026

Trends in Tuberculosis Incidence and Treatment Outcomes in Kazakhstan: A Decade of Observational Data.

Galymzhan Ryskulov, Malik Adenov, Maira Zhaparkulova, Alibek Bissembayev, Gulnar Rakhimbekova, Dariga Tanabayeva, Shynar Tanabayeva, Ildar Fakhradiyev, Marat Shoranov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Galymzhan RyskulovDepartment of Medicine, National Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan, Almaty 050010, Kazakhstan.
Malik AdenovDepartment of Medicine, National Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan, Almaty 050010, Kazakhstan.
Maira ZhaparkulovaDepartment of Medicine, National Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan, Almaty 050010, Kazakhstan.
Alibek BissembayevSchool of IT and Engineering, Kazakh-British Technical University, Almaty 050000, Kazakhstan.
Gulnar RakhimbekovaDepartment of Medicine, Astana Medical University, Astana 010000, Kazakhstan.
Dariga TanabayevaDepartment of Cellular and Physiological Sciences, Faculty of Science, University of British Colombia, Vancouver, BC V6T 1Z4, Canada.
Shynar TanabayevaDepartment of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.
Ildar FakhradiyevDepartment of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.ORCID 0000-0003-0528-3874
Marat ShoranovDepartment of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

incidenceKazakhstanretrospective studiesrisk factorstreatment outcometuberculosis

Identifiers

PMID41893410
PMCPMC13030362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.